Healthcare Stocks Lag Market on Drug Pricing…Update-2
Update-2... 945 am EDT...Biotechs Hold Support IBB up 1.55% to $285 holding support at $280; XBI up 2.99% to $61.95 holding support at $60. Update-1...More Fallout from Mylan (MYL) EpiPen Drug Pricing MYL stock was down over 4% today on news that the EpiPen was mis-classified as a generic drug...
Biotech Investors Stung By Drug Pricing Flap…Update-1
Update-1... IBB Trying to hold the $280 line after media bashing of EpiPen Pricing- now they have a generic EpiPen for half the price! Biotech outflows are a concern (-$184M) Gilead Sciences (GILD) down 2.89% on new potential competition from GlaxoSmithK (GSK) HIV double therapy drug with cost...
Pfizer (PFE) Acquisition of Medivation (MDVN) Provides Support to Biotech Stocks…Update-1 IBB Down 3.36%
Update-1 After Close 8/24 IBB at 286.23 XBI down 4.34% XLV down 1.54%, NASDAQ down 0.81% Early Afternoon Reversal Kills Biotech Rally In Heavy Trading But Mylan is not a biotech Company?? The broad based rally in biotech stocks faded around 1P EDT Wednesday as investors were spooked by the...
Today’s Movers in Life Sciences-Gene Sequencing: ILMN,PACB
Illumina (ILMN) Up 3 % to $174 on Buyout Speculation in Gene Sequencing Illumina, Inc. (ILMN) was up as much as 12 points earlier today on a rumored buyout from Thermo Fisher Scientific Inc. (TMO). Thermo bought another major player in sequencing Life Techologies for $13.6B making it the...
Large Cap Biopharmaceutical Metrics: Valuation Models for Future Growth
Large Cap Biopharmaceutical Valuation Models Can Biotech Growth Re-accelerate in Q4? We reviewed large cap biotech stocks on July 3 just after the BREXIT bottom but prior to Q2 earnings and on May 8 after Q1 earnings. Here is data that offer comparisons of the core large cap holdings in the...